U.S. flag

An official website of the United States government

NM_152296.5(ATP1A3):c.410C>T (p.Ser137Phe) AND Dystonia 12

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 13, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001234241.10

Allele description [Variation Report for NM_152296.5(ATP1A3):c.410C>T (p.Ser137Phe)]

NM_152296.5(ATP1A3):c.410C>T (p.Ser137Phe)

Gene:
ATP1A3:ATPase Na+/K+ transporting subunit alpha 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_152296.5(ATP1A3):c.410C>T (p.Ser137Phe)
HGVS:
  • NC_000019.10:g.41986177G>A
  • NG_008015.1:g.13054C>T
  • NM_001256213.2:c.443C>T
  • NM_001256214.2:c.449C>T
  • NM_152296.5:c.410C>TMANE SELECT
  • NP_001243142.1:p.Ser148Phe
  • NP_001243143.1:p.Ser150Phe
  • NP_689509.1:p.Ser137Phe
  • LRG_1186t1:c.410C>T
  • LRG_1186:g.13054C>T
  • LRG_1186p1:p.Ser137Phe
  • NC_000019.9:g.42490329G>A
  • NM_001256214.1:c.449C>T
  • NM_152296.4:c.410C>T
  • P13637:p.Ser137Phe
Protein change:
S137F
Links:
UniProtKB: P13637#VAR_068935; dbSNP: rs542652468
NCBI 1000 Genomes Browser:
rs542652468
Molecular consequence:
  • NM_001256213.2:c.443C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001256214.2:c.449C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_152296.5:c.410C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Dystonia 12 (DYT12)
Synonyms:
DYT-ATP1A3; Rapid-Onset Dystonia-Parkinsonism
Identifiers:
MONDO: MONDO:0007496; MedGen: C1868681; Orphanet: 71517; OMIM: 128235

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001406877Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 13, 2019)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.

Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, Nicole S, de Vries B, Tiziano FD, Fontaine B, Walley NM, Heavin S, Panagiotakaki E; European Alternating Hemiplegia of Childhood (AHC) Genetics Consortium.; Biobanca e Registro Clinico per l'Emiplegia Alternante (I.B.AHC) Consortium.; European Network for Research on Alternating Hemiplegia (ENRAH) for Small and Medium-sized Enterpriese (SMEs) Consortium., Fiori S, Abiusi E, Di Pietro L, Sweney MT, Newcomb TM, Viollet L, Huff C, Jorde LB, et al.

Nat Genet. 2012 Sep;44(9):1030-4. doi: 10.1038/ng.2358. Epub 2012 Jul 29.

PubMed [citation]
PMID:
22842232
PMCID:
PMC3442240

Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotype.

Jaffer F, Avbersek A, Vavassori R, Fons C, Campistol J, Stagnaro M, De Grandis E, Veneselli E, Rosewich H, Gianotta M, Zucca C, Ragona F, Granata T, Nardocci N, Mikati M, Helseth AR, Boelman C, Minassian BA, Johns S, Garry SI, Scheffer IE, Gourfinkel-An I, et al.

Brain. 2015 Oct;138(Pt 10):2859-74. doi: 10.1093/brain/awv243. Epub 2015 Aug 21.

PubMed [citation]
PMID:
26297560
PMCID:
PMC4671482
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001406877.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Ser137 amino acid residue in ATP1A3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22842232). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed in individuals affected with alternating hemiplegia of childhood (PMID: 22842232, 26297560, 26410222). ClinVar contains an entry for this variant (Variation ID: 161122). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with phenylalanine at codon 137 of the ATP1A3 protein (p.Ser137Phe). The serine residue is moderately conserved and there is a large physicochemical difference between serine and phenylalanine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024